A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features

Clara Bueno1,2,3, Raul Torres-Ruiz1,4,5,6,7, Talia Velasco-Hernandez1,2

  • 1Stem Cell Biology, Immunotherapy and Developmental Leukemia Laboratory. Josep Carreras Leukemia Research Institute, Barcelona, Spain.

Blood
|September 27, 2023
PubMed